199 related articles for article (PubMed ID: 15809277)
1. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes.
Gibbons RJ
Hum Mol Genet; 2005 Apr; 14 Spec No 1():R85-92. PubMed ID: 15809277
[TBL] [Abstract][Full Text] [Related]
2. Histone modification enzymes: novel targets for cancer drugs.
Kristeleit R; Stimson L; Workman P; Aherne W
Expert Opin Emerg Drugs; 2004 May; 9(1):135-54. PubMed ID: 15155140
[TBL] [Abstract][Full Text] [Related]
3. Histone modifying enzymes and cancer: going beyond histones.
Zhang K; Dent SY
J Cell Biochem; 2005 Dec; 96(6):1137-48. PubMed ID: 16173079
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic silencing of the MGMT gene in cancer.
Soejima H; Zhao W; Mukai T
Biochem Cell Biol; 2005 Aug; 83(4):429-37. PubMed ID: 16094446
[TBL] [Abstract][Full Text] [Related]
5. Dominant-negative histone H3 lysine 27 mutant derepresses silenced tumor suppressor genes and reverses the drug-resistant phenotype in cancer cells.
Abbosh PH; Montgomery JS; Starkey JA; Novotny M; Zuhowski EG; Egorin MJ; Moseman AP; Golas A; Brannon KM; Balch C; Huang TH; Nephew KP
Cancer Res; 2006 Jun; 66(11):5582-91. PubMed ID: 16740693
[TBL] [Abstract][Full Text] [Related]
6. Aberrant de novo methylation of the p16INK4A CpG island is initiated post gene silencing in association with chromatin remodelling and mimics nucleosome positioning.
Hinshelwood RA; Melki JR; Huschtscha LI; Paul C; Song JZ; Stirzaker C; Reddel RR; Clark SJ
Hum Mol Genet; 2009 Aug; 18(16):3098-109. PubMed ID: 19477956
[TBL] [Abstract][Full Text] [Related]
7. The clinical application of targeting cancer through histone acetylation and hypomethylation.
Gilbert J; Gore SD; Herman JG; Carducci MA
Clin Cancer Res; 2004 Jul; 10(14):4589-96. PubMed ID: 15269129
[TBL] [Abstract][Full Text] [Related]
8. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
Clark SJ
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
[TBL] [Abstract][Full Text] [Related]
9. Reversal of gene silencing as a therapeutic target for cancer--roles for DNA methylation and its interdigitation with chromatin.
Baylin SB
Novartis Found Symp; 2004; 259():226-33; discussion 234-7, 285-8. PubMed ID: 15171257
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic control of ovarian function: the emerging role of histone modifications.
LaVoie HA
Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
12. DNMT cooperativity--the developing links between methylation, chromatin structure and cancer.
El-Osta A
Bioessays; 2003 Nov; 25(11):1071-84. PubMed ID: 14579248
[TBL] [Abstract][Full Text] [Related]
13. Histone acetylation in gene regulation.
Verdone L; Agricola E; Caserta M; Di Mauro E
Brief Funct Genomic Proteomic; 2006 Sep; 5(3):209-21. PubMed ID: 16877467
[TBL] [Abstract][Full Text] [Related]
14. Chromatin-remodelling mechanisms in cancer.
Lafon-Hughes L; Di Tomaso MV; Méndez-Acuña L; Martínez-López W
Mutat Res; 2008; 658(3):191-214. PubMed ID: 18403253
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic control of cellular senescence in disease: opportunities for therapeutic intervention.
Atkinson SP; Keith WN
Expert Rev Mol Med; 2007 Mar; 9(7):1-26. PubMed ID: 17352843
[TBL] [Abstract][Full Text] [Related]
16. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing.
Marban C; Suzanne S; Dequiedt F; de Walque S; Redel L; Van Lint C; Aunis D; Rohr O
EMBO J; 2007 Jan; 26(2):412-23. PubMed ID: 17245431
[TBL] [Abstract][Full Text] [Related]
17. Histone-modifying enzymes: encrypting an enigmatic epigenetic code.
Couture JF; Trievel RC
Curr Opin Struct Biol; 2006 Dec; 16(6):753-60. PubMed ID: 17070031
[TBL] [Abstract][Full Text] [Related]
18. Caught in conspiracy: cooperation between DNA methylation and histone H3K9 methylation in the establishment and maintenance of heterochromatin.
Stancheva I
Biochem Cell Biol; 2005 Jun; 83(3):385-95. PubMed ID: 15959564
[TBL] [Abstract][Full Text] [Related]
19. Dormant hypermethylated tumour suppressor genes: questions and answers.
Esteller M
J Pathol; 2005 Jan; 205(2):172-80. PubMed ID: 15643671
[TBL] [Abstract][Full Text] [Related]
20. Small molecule modulators in epigenetics: implications in gene expression and therapeutics.
Swaminathan V; Reddy BA; Ruthrotha Selvi B; Sukanya MS; Kundu TK
Subcell Biochem; 2007; 41():397-428. PubMed ID: 17484138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
